ADV7103
Phase 1Completed 0 watching 0 views this week💤 Quiet
25
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
EFFECT OF ADV7103 ON GASTRIC PH
Conditions
EFFECT OF ADV7103 ON GASTRIC PH, Distal Renal Tublular Acidosis
Trial Timeline
Feb 25, 2025 → Mar 15, 2025
NCT ID
NCT07446881About ADV7103
ADV7103 is a phase 1 stage product being developed by Advicenne for EFFECT OF ADV7103 ON GASTRIC PH. The current trial status is completed. This product is registered under clinical trial identifier NCT07446881. Target conditions include EFFECT OF ADV7103 ON GASTRIC PH, Distal Renal Tublular Acidosis.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07446881 | Phase 1 | Completed |
| NCT03831152 | Phase 3 | Withdrawn |
Competing Products
20 competing products in EFFECT OF ADV7103 ON GASTRIC PH